ReP USP - Resultado da busca

Artigo de periodico
Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-Positive NSCLC: primary efficacy results from the ASCEND-8 study (2019)
Cho, Byoung Chul; Obermannova, Radka; Bearz, Alessandra; Mckeage, Mark; Kim, Dong-Wang; Batra, Ullas; Borra, Gloria; Orlov, Sergey; Kim, Sang-We; Castro Junior, Gilberto de
Source: Journal of thoracic oncology. Unidade: FM
Subjects: NEOPLASIAS PULMONARES, PROTEÍNAS QUINASES, JEJUM, ALIMENTOS, GASTROENTEROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHO, Byoung Chul et al. Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-Positive NSCLC: primary efficacy results from the ASCEND-8 study. Journal of thoracic oncology, v. 14, n. 7, p. 1255-1265, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jtho.2019.03.002. Acesso em: 18 nov. 2024.
APA
Cho, B. C., Obermannova, R., Bearz, A., Mckeage, M., Kim, D. -W., Batra, U., et al. (2019). Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-Positive NSCLC: primary efficacy results from the ASCEND-8 study. Journal of thoracic oncology, 14( 7), 1255-1265. doi:10.1016/j.jtho.2019.03.002
NLM
Cho BC, Obermannova R, Bearz A, Mckeage M, Kim D-W, Batra U, Borra G, Orlov S, Kim S-W, Castro Junior G de. Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-Positive NSCLC: primary efficacy results from the ASCEND-8 study [Internet]. Journal of thoracic oncology. 2019 ; 14( 7): 1255-1265.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.jtho.2019.03.002
Vancouver
Cho BC, Obermannova R, Bearz A, Mckeage M, Kim D-W, Batra U, Borra G, Orlov S, Kim S-W, Castro Junior G de. Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-Positive NSCLC: primary efficacy results from the ASCEND-8 study [Internet]. Journal of thoracic oncology. 2019 ; 14( 7): 1255-1265.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.jtho.2019.03.002
Artigo de periodico
Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer (2019)
Kirschbrown, Whitney P; Wang, Bei; Nijem, Ihsan; Ohtsu, Atsushi; Hoff, Paulo Marcelo Gehm ; Shah, Manish A; Shen, Lin; Kang, Yoon-Koo; Alsina, Maria; Girish, Sandhya; Garg, Amit
Source: Cancer chemotherapy and pharmacology. Unidade: FM
Subjects: ANTICORPOS MONOCLONAIS, NEOPLASIAS GÁSTRICAS, METÁSTASE NEOPLÁSICA, QUIMIOTERAPIA COMBINADA, RECEPTORES DE SUPERFÍCIE CELULAR, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIRSCHBROWN, Whitney P et al. Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer. Cancer chemotherapy and pharmacology, v. 84, n. 3, p. 539-550, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00280-019-03871-w. Acesso em: 18 nov. 2024.
APA
Kirschbrown, W. P., Wang, B., Nijem, I., Ohtsu, A., Hoff, P. M. G., Shah, M. A., et al. (2019). Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer. Cancer chemotherapy and pharmacology, 84( 3), 539-550. doi:10.1007/s00280-019-03871-w
NLM
Kirschbrown WP, Wang B, Nijem I, Ohtsu A, Hoff PMG, Shah MA, Shen L, Kang Y-K, Alsina M, Girish S, Garg A. Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer [Internet]. Cancer chemotherapy and pharmacology. 2019 ; 84( 3): 539-550.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00280-019-03871-w
Vancouver
Kirschbrown WP, Wang B, Nijem I, Ohtsu A, Hoff PMG, Shah MA, Shen L, Kang Y-K, Alsina M, Girish S, Garg A. Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer [Internet]. Cancer chemotherapy and pharmacology. 2019 ; 84( 3): 539-550.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00280-019-03871-w
Artigo de periodico
The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes (2010)
Costa, Simone V. da; Roela, Rosimeire A.; Junqueira, Mara Souza; Arantes, Camila; Brentani, Maria Mitzi
Source: Leukemia Research. Unidade: FM
Subjects: PROTEÍNAS QUINASES, LEUCEMIA, NEOPLASIAS DA MEDULA ESPINHAL, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Simone V. da et al. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes. Leukemia Research, v. 34, n. 4, p. 507-512, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2009.10.012. Acesso em: 18 nov. 2024.
APA
Costa, S. V. da, Roela, R. A., Junqueira, M. S., Arantes, C., & Brentani, M. M. (2010). The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes. Leukemia Research, 34( 4), 507-512. doi:10.1016/j.leukres.2009.10.012
NLM
Costa SV da, Roela RA, Junqueira MS, Arantes C, Brentani MM. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes [Internet]. Leukemia Research. 2010 ; 34( 4): 507-512.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.012
Vancouver
Costa SV da, Roela RA, Junqueira MS, Arantes C, Brentani MM. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes [Internet]. Leukemia Research. 2010 ; 34( 4): 507-512.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.012
Artigo de periodico
Guanosine promotes B16F10 melanoma cell differentiation through PKC–ERK 1/2 pathway (2008)
Naliwaiko, Katya; Luvizon, Aline C.; Donatti, Lucélia; Chammas, Roger; Mercadante, Adriana F.; Zanata, Silvio M.; Nakao, Lia S.
Source: Chemico-Biological Interactions. Unidade: FM
Subjects: MELANOMA, PROTEÍNAS QUINASES, NEOPLASIAS CUTÂNEAS, ISQUEMIA, DIFERENCIAÇÃO CELULAR, CULTURA DE CÉLULAS, QUIMIOTERAPIA ADJUVANTE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NALIWAIKO, Katya et al. Guanosine promotes B16F10 melanoma cell differentiation through PKC–ERK 1/2 pathway. Chemico-Biological Interactions, v. 173, n. 2, p. 122-128, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2008.03.010. Acesso em: 18 nov. 2024.
APA
Naliwaiko, K., Luvizon, A. C., Donatti, L., Chammas, R., Mercadante, A. F., Zanata, S. M., & Nakao, L. S. (2008). Guanosine promotes B16F10 melanoma cell differentiation through PKC–ERK 1/2 pathway. Chemico-Biological Interactions, 173( 2), 122-128. doi:10.1016/j.cbi.2008.03.010
NLM
Naliwaiko K, Luvizon AC, Donatti L, Chammas R, Mercadante AF, Zanata SM, Nakao LS. Guanosine promotes B16F10 melanoma cell differentiation through PKC–ERK 1/2 pathway [Internet]. Chemico-Biological Interactions. 2008 ; 173( 2): 122-128.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.cbi.2008.03.010
Vancouver
Naliwaiko K, Luvizon AC, Donatti L, Chammas R, Mercadante AF, Zanata SM, Nakao LS. Guanosine promotes B16F10 melanoma cell differentiation through PKC–ERK 1/2 pathway [Internet]. Chemico-Biological Interactions. 2008 ; 173( 2): 122-128.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.cbi.2008.03.010

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em